Catalyst Wire Dossier Catalyst Wire Dossier

NEULASTA

pegfilgrastim · Amgen, Inc
Drug timelines are a Plus or Pro feature.

54 regulatory and trial events tracked for NEULASTA, covering 2006-10-25 to 2026-08-04. Get the full timeline:

Most recent: FDA Approved: NEULASTA — Supplemental Application (Amgen, Inc)

See pricing